Cormorant Asset Management LP 13D and 13G filings for Bright Minds Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-06 4:06 pm Purchase |
2024-11-04 | 13G | Bright Minds Biosciences Inc. DRUG |
Cormorant Asset Management LP | 1,059,331 17.260% |
184,331 (+21.07%) |
Filing |
| 2024-10-22 4:03 pm Purchase |
2024-10-15 | 13G | Bright Minds Biosciences Inc. DRUG |
Cormorant Asset Management LP | 875,000 18.790% |
875,000 (New Position) |
Filing |